More than a year after we began our video series covering biopharma’s response to COVID-19, Portfolio Manager and Research Analyst Dan Lyons discusses how vaccines are offering a path out of the pandemic and the potential impact to health care long term.

Key Takeaways

  • Countries that have achieved high vaccination rates have also seen a precipitous drop in COVID-19 cases, offering real-world proof of vaccines’ efficacy.
  • Vaccine distribution varies dramatically across countries but that has more to do with manufacturing capacity, not patent protections.
  • We may now have a road map for ending the pandemic, but some changes in health care could be here to stay, including a greater appreciation for vaccines and improved diagnostics.